Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to the treatment of and education on sickle cell disease and the sickle cell task force.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to informed consent before provision of certain medical treatments and exemptions from COVID-19 vaccination requirements.
Relating to gender modification procedures and treatments for certain minors; providing a civil penalty.
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Relating to informed consent before provision of certain medical treatments and exemptions from COVID-19 vaccination requirements.